Nuvaxovid – A novel vaccine is expected to be approved in Europe soon. But so far there are only a few empirical values.
The corona pandemic is still widespread. The numbers are currently rising again and the first place among the corona measures that the federal government is pushing is still the vaccination campaign. But many German citizens are still hesitant to get vaccinated against Corona. A new vaccine should now help against this. A so-called dead vaccine. What the Novavax vaccine is all about, and what side effects are known so far, reports echo24.de *
According to media reports, Novavax is now expecting approval in Europe in the next few weeks. Then the inactivated vaccine “Nuvaxovid” should be the fifth approved vaccine in Germany. The EU secured up to 200 million doses of the new vaccine in August. * echo24.de is an offer from IPPEN.MEDIA.
